Ordering Recommendation
Determine the patient's blood type (ABO and Rh D) in prenatal patients only, to evaluate possible risk for hemolytic disease of the fetus and newborn (HDFN) and to evaluate if the patient is a candidate for Rh Immunoglobulin.
Mnemonic
ABORH-PR
Methodology
Hemagglutination
Performed
Mon-Fri
Reported
1-3 days
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
Collect
Lavender (K2EDTA) or Pink (K2EDTA).
Specimen Preparation
Transport 7 mL whole blood. (Min: 3 mL)
Storage/Transport Temperature
Refrigerated.
Unacceptable Conditions
Remarks
Stability
Ambient: Unacceptable; Refrigerated: 1 week; Frozen: Unacceptable
Reference Interval
ABO Typing: A, B, AB, O
Rh Typing: Rh positive/Rh negative
Interpretive Data
Compliance Category
FDA
Note
Hotline History
Hotline History
Date of Change
Test Name Change
Methodology
Performance/Reported Schedule
Specimen Requirements
Reference Interval
Interpretive Data
Note
CPT Code
Component Change
Other Interface Change
New Test
Inactive
N/A
CPT Codes
86900; 86901
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
0010016 | ABORh Prenatal | 882-1 |
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
- Blood Type, Prenatal
ABO-Rh Prenatal